Related Experiment Video

Updated: Jun 13, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

TGFbeta and cancer metastasis: an inflammation link

Li Yang1

  • 1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD 20876-4258, USA. yangl3@mail.nih.gov

Cancer Metastasis Reviews
|May 4, 2010
PubMed

Insights

Transforming growth factor beta (TGFbeta) has a dual role in cancer, acting as both a tumor suppressor and promoter. Understanding the mechanisms behind this switch is crucial for developing effective TGFbeta-targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Dysregulated transforming growth factor beta (TGFbeta) signaling is implicated in various human cancers.
  • TGFbeta exhibits a dual role, functioning as a tumor suppressor in early stages and a promoter in later stages of cancer.
  • This complex role presents significant challenges for TGFbeta-targeted cancer therapies.

Purpose of the Study:

  • To investigate the underlying mechanisms of TGFbeta's dual role in cancer.
  • To identify factors mediating the switch in TGFbeta's function during tumorigenesis.
  • To explore the impact of TGFbeta on the tumor microenvironment and immune responses.

Main Methods:

  • Analysis of TGFbeta signaling pathways.
  • Investigation of tumor cell-autonomous TGFbeta signaling.
  • Elucidation of TGFbeta's effects on host immune and inflammatory reactions.

Main Results:

  • TGFbeta signaling is dysregulated in numerous cancer types.
  • The switch in TGFbeta's function from suppressor to promoter is not fully understood.
  • Recent research highlights the importance of the tumor microenvironment and immune system in mediating TGFbeta's effects.

Conclusions:

  • Understanding the mechanisms behind TGFbeta's dual role is essential for effective cancer therapy.
  • Further research into TGFbeta's interaction with the tumor microenvironment and immune system is warranted.
  • Targeting TGFbeta signaling requires careful consideration of its context-dependent functions in cancer.

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.